SCHEMBL7431017

SCHEMBL7431017

ClC1=CCCCC1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9028184 0.72
SCHEMBL8786738 0.72
SCHEMBL7265102 0.72
SCHEMBL8786649 0.72
SCHEMBL12945064 0.72
SCHEMBL23894380 0.72
SCHEMBL31297943 0.72
SCHEMBL10575890 0.72
SCHEMBL14428496 0.72
SCHEMBL29526569 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0322914-B1 Novel sulfhydryl containing tricyclic lactams and their pharmacological methods of use MERRELL DOW PHARMA (US) 1994-01-19 EP disclosed
CN-1020612-C METHOD FOR PREPARING ANTIHYPERTENSIVE TRICYCLIC LACTAM DERIVS. MERRELL PHARMA INC (US) 1993-05-12 CN disclosed
US-5095110-A Process for the preparation of sulfhydryl containing tricyclic lactams MERRELL DOW PHARMACEUTICALS INC. (US) 1992-03-10 US disclosed
US-4973585-A INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME MERRELL DOW PHARMACEUTICALS (US) 1990-11-27 US disclosed
CN-1034721-A New tricyclic lactam that contains sulfydryl and the method for on pharmacology, using thereof MERRELL DOW PHARMA (US) 1989-08-16 CN disclosed
US-4824832-A INHIBIT ANGIOTENSIN CONVERTING ENZYME MERRELL DOW PHARMACEUTICALS INC. (US) 1989-04-25 US disclosed